Pro Medicus Ltd banner

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 138.34 AUD -2.32% Market Closed
Market Cap: AU$14.5B

EV/OCF

111.3
Current
35%
Cheaper
vs 3-y average of 171

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
111.3
=
Enterprise Value
AU$11.8B
/
Operating Cash Flow
AU$127.8m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
111.3
=
Enterprise Value
AU$11.8B
/
Operating Cash Flow
AU$127.8m

Valuation Scenarios

Pro Medicus Ltd is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (171), the stock would be worth AU$212.5 (54% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-87%
Maximum Upside
+54%
Average Downside
22%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 111.3 AU$138.34
0%
3-Year Average 171 AU$212.5
+54%
5-Year Average 145.2 AU$180.54
+31%
Industry Average 17.4 AU$21.68
-84%
Country Average 14.1 AU$17.51
-87%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
AU
Pro Medicus Ltd
ASX:PME
14.5B AUD 111.3 61.6
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 79.3 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 18.9 53.1
US
Veeva Systems Inc
NYSE:VEEV
26.4B USD 13.9 29
JP
M3 Inc
TSE:2413
1T JPY 13.6 20.5
SE
Sectra AB
STO:SECT B
51.8B SEK 63.2 96.4
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD 19.8 42.4
US
Doximity Inc
NYSE:DOCS
4.4B USD 11.8 18.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.3B CNY 38.2 -62.7
US
Vocera Communications Inc
F:V00
2.4B EUR 61.3 -328
US
Heartflow Inc
NASDAQ:HTFL
2.6B USD 0 0
P/E Multiple
Earnings Growth PEG
AU
Pro Medicus Ltd
ASX:PME
Average P/E: 68.6
61.6
29%
2.1
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
29
27%
1.1
JP
M3 Inc
TSE:2413
20.5
16%
1.3
SE
Sectra AB
STO:SECT B
96.4
14%
6.9
US
W
Waystar Holding Corp
NASDAQ:WAY
42.4
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.6
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -62.7
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A

Market Distribution

Higher than 92% of companies in Australia
Percentile
92st
Based on 1 376 companies
92st percentile
111.3
Low
0 — 9.3
Typical Range
9.3 — 24.1
High
24.1 —
Distribution Statistics
Australia
Min 0
30th Percentile 9.3
Median 14.1
70th Percentile 24.1
Max 9 251.5

Pro Medicus Ltd
Glance View

Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.

PME Intrinsic Value
22.19 AUD
Overvaluation 84%
Intrinsic Value
Price AU$138.34
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett